一种高效的自动减压药物转移装置,用于抗癌药物,具有卓越的封闭性能
Liming Xie1, Guanfeng Chen1, Qianqian Ouyang2
1Department of Pharmacy, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Frontiers in pharmacology
|May 12, 2025
概括
一种名为CSTD (JLY) 的新型封闭系统药物传输装置 (CSTD) 显著减少了药物泄漏和操作员手的负担. 这种创新设备提高了医疗保健工作人员处理危险药物的安全性.
科学领域:
- 职业健康 职业健康 职业健康
- 制药技术 制药技术 制药技术
- 药物输送系统 药物输送系统
背景情况:
- 医疗保健工作者因接触危险药物而面临重大健康风险.
- 目前的药物传输方法可能会导致药物泄漏和增加操作员压力.
- 需要先进的设备来减轻这些风险.
研究的目的:
- 开发和评估一种名为CSTD (JLY) 的新型封闭系统药物传输装置 (CSTD).
- 评估CSTD (JLY) 在预防药物暴露方面的封闭性表现和有效性.
- 为了减少医疗保健工作人员在药物转移期间的身体负担.
主要方法:
- 通过将其与标准注射器进行比较,研究了CSTD (JLY) 的闭合性能.
- 使用模拟药物 (光素),常见药物 (兰索普拉,尼莫迪平,热) 和抗癌药物 (cyclophosphamide) 进行评估.
- 在模拟药物转移过程中评估药物泄漏和暴露潜力.
主要成果:
- 与传统注射器相比,CSTD (JLY) 显示药物泄漏明显减少.
- 具有自动减压结构的新型CSTD表现出卓越的闭合性能.
- 该设备有效地解决了药物转移期间液体药物泄漏的问题.
结论:
- CSTD (JLY) 为医疗保健专业人员提供了对危险药物暴露的增强保护.
- 自动减压功能通过减少操作员手的负担来提高可用性.
- 这种创新的CSTD有助于为医疗保健工作者和患者提供更安全的环境.
更多相关视频
09:58Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
Published on: April 23, 2015
9.0K
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.3K
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
01:27Drug Delivery Systems: Different Types
418
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
418
01:23Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
01:26Oral Drug Delivery Systems: Continuous-Release Systems
319
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
319
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
211
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
211